Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Sep;110(1):416–422. doi: 10.1111/j.1476-5381.1993.tb13826.x

E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin.

M M Teixeira 1, T J Williams 1, P G Hellewell 1
PMCID: PMC2176016  PMID: 7693286

Abstract

1. Prostaglandins possess both pro- and anti-inflammatory actions depending on their route of administration and the experimental model used. In this study, we have investigated the effect of locally injected prostaglandins on oedema formation, neutrophil accumulation and eosinophil accumulation in inflammatory responses in guinea-pig skin. 2. Prostaglandin E1 (PGE1) significantly enhanced local oedema formation induced by zymosan-activated plasma (ZAP), bradykinin and in a passive cutaneous anaphylactic (PCA) reaction. The accumulation of ZAP-induced 111In-labelled neutrophils was also significantly enhanced by PGE1. In addition, the prostacyclin analogue, iloprost, enhanced ZAP-induced responses. 3. In contrast PGE1 decreased the accumulation of 111In-labelled eosinophils in skin sites. This was demonstrated on eosinophil accumulation and local oedema formation induced by PAF, compound 48/80 and in the PCA reaction. PGE2 also suppressed eosinophil accumulation while iloprost had no detectable effect. 4. Isoprenaline inhibited eosinophil accumulation in a dose-dependent manner with no effect on local oedema formation, except in the case of responses to ZAP where suppression was observed. 5. The vasodilator neuropeptide, calcitonin gene-related peptide (CGRP), enhanced local oedema formation but had no detectable effect on eosinophil accumulation. 6. In conclusion, the magnitude of a given response to an inflammatory mediator in vivo depends on the net effect of stimulation of several cell types e.g. arteriolar smooth muscle cells, microvascular endothelial cells, mast cells and accumulating leukocytes. In this study, we have demonstrated that different components of the inflammatory response in guinea-pig skin can be differentially modulated by E-type prostaglandins and isoprenaline, suggesting that cyclic AMP has an important regulatory role.

Full text

PDF
416

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Kowalski W. J., Strulovici B. Effects of enprostil on platelets, endothelial cells, and other cell types, and second messenger systems by which these effects are mediated. Am J Med. 1986 Aug 18;81(2A):34–39. doi: 10.1016/s0002-9343(86)80008-0. [DOI] [PubMed] [Google Scholar]
  2. Anastassiou E. D., Paliogianni F., Balow J. P., Yamada H., Boumpas D. T. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J Immunol. 1992 May 1;148(9):2845–2852. [PubMed] [Google Scholar]
  3. Beets J. L., Paul W. Actions of locally administered adrenoceptor agonists on increased plasma protein extravasation and blood flow in guinea-pig skin. Br J Pharmacol. 1980 Nov;70(3):461–467. doi: 10.1111/j.1476-5381.1980.tb08724.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brain S. D., Williams T. J., Tippins J. R., Morris H. R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985 Jan 3;313(5997):54–56. doi: 10.1038/313054a0. [DOI] [PubMed] [Google Scholar]
  5. Buckley T. L., Brain S. D., Collins P. D., Williams T. J. Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J Immunol. 1991 May 15;146(10):3424–3430. [PubMed] [Google Scholar]
  6. Burgers J. A., Schweizer R. C., Koenderman L., Bruijnzeel P. L., Akkerman J. W. Human platelets secrete chemotactic activity for eosinophils. Blood. 1993 Jan 1;81(1):49–55. [PubMed] [Google Scholar]
  7. Chopra J., Webster R. O. PGE1 inhibits neutrophil adherence and neutrophil-mediated injury to cultured endothelial cells. Am Rev Respir Dis. 1988 Oct;138(4):915–920. doi: 10.1164/ajrccm/138.4.915. [DOI] [PubMed] [Google Scholar]
  8. Djukanović R., Roche W. R., Wilson J. W., Beasley C. R., Twentyman O. P., Howarth R. H., Holgate S. T. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990 Aug;142(2):434–457. doi: 10.1164/ajrccm/142.2.434. [DOI] [PubMed] [Google Scholar]
  9. Faccioli L. H., Nourshargh S., Moqbel R., Williams F. M., Sehmi R., Kay A. B., Williams T. J. The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology. 1991 Jun;73(2):222–227. [PMC free article] [PubMed] [Google Scholar]
  10. Fantone J. C., Kunkel S. L., Ward P. A., Zurier R. B. Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators. J Immunol. 1980 Dec;125(6):2591–2596. [PubMed] [Google Scholar]
  11. Folkerts G., Engels F., Nijkamp F. P. Endotoxin-induced hyperreactivity of the guinea-pig isolated trachea coincides with decreased prostaglandin E2 production by the epithelial layer. Br J Pharmacol. 1989 Feb;96(2):388–394. doi: 10.1111/j.1476-5381.1989.tb11829.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goltzman D., Mitchell J. Interaction of calcitonin and calcitonin gene-related peptide at receptor sites in target tissues. Science. 1985 Mar 15;227(4692):1343–1345. doi: 10.1126/science.2983422. [DOI] [PubMed] [Google Scholar]
  13. Gray P. R., Derksen F. J., Broadstone R. V., Robinson N. E., Peters-Golden M. Decreased airway mucosal prostaglandin E2 production during airway obstruction in an animal model of asthma. Am Rev Respir Dis. 1992 Sep;146(3):586–591. doi: 10.1164/ajrccm/146.3.586. [DOI] [PubMed] [Google Scholar]
  14. Hopkins N. K., Gorman R. R. Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin. J Clin Invest. 1981 Feb;67(2):540–546. doi: 10.1172/JCI110064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Issekutz A. C. Effect of vasoactive agents on polymorphonuclear leukocyte emigration in vivo. Lab Invest. 1981 Sep;45(3):234–240. [PubMed] [Google Scholar]
  16. Issekutz A. C., Movat H. Z. The effect of vasodilator prostaglandins on polymorphonuclear leukocyte infiltration and vascular injury. Am J Pathol. 1982 Jun;107(3):300–309. [PMC free article] [PubMed] [Google Scholar]
  17. Kameyoshi Y., Dörschner A., Mallet A. I., Christophers E., Schröder J. M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med. 1992 Aug 1;176(2):587–592. doi: 10.1084/jem.176.2.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kita H., Abu-Ghazaleh R. I., Gleich G. J., Abraham R. T. Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate. J Immunol. 1991 Apr 15;146(8):2712–2718. [PubMed] [Google Scholar]
  19. Kuehl F. A., Jr, Zanetti M. E., Soderman D. D., Miller D. K., Ham E. A. Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma. Am Rev Respir Dis. 1987 Jul;136(1):210–213. doi: 10.1164/ajrccm/136.1.210. [DOI] [PubMed] [Google Scholar]
  20. Kunkel S. L., Thrall R. S., Kunkel R. G., McCormick J. R., Ward P. A., Zurier R. B. Suppression of immune complex vasculitis in rats by prostaglandin. J Clin Invest. 1979 Nov;64(5):1525–1529. doi: 10.1172/JCI109611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lellouch-Tubiana A., Lefort J., Simon M. T., Pfister A., Vargaftig B. B. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Am Rev Respir Dis. 1988 Apr;137(4):948–954. doi: 10.1164/ajrccm/137.4.948. [DOI] [PubMed] [Google Scholar]
  22. MAJNO G., PALADE G. E. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol. 1961 Dec;11:571–605. doi: 10.1083/jcb.11.3.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Moncada S., Ferreira S. H., Vane J. R. Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature. 1973 Nov 23;246(5430):217–219. doi: 10.1038/246217a0. [DOI] [PubMed] [Google Scholar]
  24. Morikawa M., Aikawa T., Sekizawa K., Ohrui T., Sasaki H., Takishima T. Inhibitory actions of prostaglandin E1 on neurogenic plasma extravasation in rat airways. Eur J Pharmacol. 1992 Jun 24;217(1):31–35. doi: 10.1016/0014-2999(92)90507-z. [DOI] [PubMed] [Google Scholar]
  25. Numao T., Agrawal D. K. Neuropeptides modulate human eosinophil chemotaxis. J Immunol. 1992 Nov 15;149(10):3309–3315. [PubMed] [Google Scholar]
  26. Pavord I. D., Wisniewski A., Tattersfield A. E. Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. Thorax. 1992 Oct;47(10):797–800. doi: 10.1136/thx.47.10.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Plaut M., Marone G., Thomas L. L., Lichtenstein L. M. Cyclic nucleotides in immune responses and allergy. Adv Cyclic Nucleotide Res. 1980;12:161–172. [PubMed] [Google Scholar]
  28. Salmon J. A., Higgs G. A. Prostaglandins and leukotrienes as inflammatory mediators. Br Med Bull. 1987 Apr;43(2):285–296. doi: 10.1093/oxfordjournals.bmb.a072183. [DOI] [PubMed] [Google Scholar]
  29. Schulman E. S., Adkinson N. F., Jr, Newball H. H. Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma. J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):589–595. doi: 10.1152/jappl.1982.53.3.589. [DOI] [PubMed] [Google Scholar]
  30. Takenawa T., Ishitoya J., Nagai Y. Inhibitory effect of prostaglandin E2, forskolin, and dibutyryl cAMP on arachidonic acid release and inositol phospholipid metabolism in guinea pig neutrophils. J Biol Chem. 1986 Jan 25;261(3):1092–1098. [PubMed] [Google Scholar]
  31. Torphy T. J., Undem B. J. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax. 1991 Jul;46(7):512–523. doi: 10.1136/thx.46.7.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  33. Wedmore C. V., Williams T. J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981 Feb 19;289(5799):646–650. doi: 10.1038/289646a0. [DOI] [PubMed] [Google Scholar]
  34. Weg V. B., Watson M. L., Cordeiro R. S., Williams T. J. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis. Eur J Pharmacol. 1991 Nov 5;204(2):157–163. doi: 10.1016/0014-2999(91)90700-z. [DOI] [PubMed] [Google Scholar]
  35. Weg V. B., Williams T. J., Lobb R. R., Nourshargh S. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med. 1993 Feb 1;177(2):561–566. doi: 10.1084/jem.177.2.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wenzel S. E., Westcott J. Y., Smith H. R., Larsen G. L. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis. 1989 Feb;139(2):450–457. doi: 10.1164/ajrccm/139.2.450. [DOI] [PubMed] [Google Scholar]
  37. Williams T. J., Hellewell P. G. Endothelial cell biology. Adhesion molecules involved in the microvascular inflammatory response. Am Rev Respir Dis. 1992 Nov;146(5 Pt 2):S45–S50. doi: 10.1164/ajrccm/146.5_Pt_2.S45. [DOI] [PubMed] [Google Scholar]
  38. Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973 Nov 23;246(5430):215–217. doi: 10.1038/246215a0. [DOI] [PubMed] [Google Scholar]
  39. Williams T. J., Peck M. J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature. 1977 Dec 8;270(5637):530–532. doi: 10.1038/270530a0. [DOI] [PubMed] [Google Scholar]
  40. Zurier R. B. Prostaglandins, immune responses, and murine lupus. Arthritis Rheum. 1982 Jul;25(7):804–809. doi: 10.1002/art.1780250718. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES